GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (OSTO:SEDANA) » Definitions » Capex-to-Revenue

Sedana Medical AB (OSTO:SEDANA) Capex-to-Revenue : 1.07 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sedana Medical AB Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Sedana Medical AB's Capital Expenditure for the three months ended in Mar. 2024 was kr-52.09 Mil. Its Revenue for the three months ended in Mar. 2024 was kr48.82 Mil.

Hence, Sedana Medical AB's Capex-to-Revenue for the three months ended in Mar. 2024 was 1.07.


Sedana Medical AB Capex-to-Revenue Historical Data

The historical data trend for Sedana Medical AB's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sedana Medical AB Capex-to-Revenue Chart

Sedana Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.76 0.60 0.69 1.12 1.10

Sedana Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 1.23 1.22 0.94 1.07

Competitive Comparison of Sedana Medical AB's Capex-to-Revenue

For the Medical Devices subindustry, Sedana Medical AB's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sedana Medical AB's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sedana Medical AB's Capex-to-Revenue falls into.



Sedana Medical AB Capex-to-Revenue Calculation

Sedana Medical AB's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-168.888) / 153.867
=1.10

Sedana Medical AB's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-52.09) / 48.821
=1.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sedana Medical AB  (OSTO:SEDANA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Sedana Medical AB Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sedana Medical AB's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sedana Medical AB (OSTO:SEDANA) Business Description

Traded in Other Exchanges
Address
Vendevagen 89, Danderyd, SWE, SE-182 32
Sedana Medical AB is a Sweden-based medical technology company. It's Anaesthetic Conserving Device (AnaConDa) is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as isoflurane or sevoflurane to invasively ventilated patients. AnaConDa is a small device that is inserted in the breathing circuit between the ET-Tube and the Y-piece. The product range of the group is AnaConDa, AnaConDa-S, AnaConDa syringe, FlurAbsorb-S, FlurAbsorb accessory kit, Nafion line, and others. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Sedana Medical AB (OSTO:SEDANA) Headlines

No Headlines